Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$13.88 -2.3%	$12.09	$10.45 ▼ $21.69	$4.91B	0.62	721,577 shs	388,566 shs
CNMD CONMED	$51.21 -4.4%	$55.66	$46.00 ▼ $78.19	$1.58B	1.2	446,763 shs	333,935 shs
GKOS Glaukos	$103.68 -2.7%	$96.86	$77.10 ▼ $163.71	$5.92B	0.82	742,262 shs	660,520 shs
MMSI Merit Medical Systems	$93.49 -1.8%	$94.74	$82.62 ▼ $111.45	$5.53B	0.65	538,384 shs	448,468 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	+0.78%	+2.60%	+12.84%	+24.58%	-8.21%
CNMD CONMED	+1.27%	-1.40%	-9.88%	+3.61%	-17.88%
GKOS Glaukos	+1.53%	+3.04%	+11.47%	+18.44%	-11.22%
MMSI Merit Medical Systems	-0.87%	+1.73%	0.00%	+3.40%	+9.15%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLCO Bausch + Lomb	2.521 of 5 stars	2.1	2.0	0.0	0.0	2.8	1.7	2.5
CNMD CONMED	4.7083 of 5 stars	2.1	3.0	2.5	4.3	3.3	0.8	3.1
GKOS Glaukos	4.4062 of 5 stars	4.4	1.0	0.0	4.4	2.4	1.7	0.6
MMSI Merit Medical Systems	4.4264 of 5 stars	3.4	2.0	0.0	3.8	2.8	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLCO Bausch + Lomb	2.17	Hold	$15.45	10.44% Upside
CNMD CONMED	2.20	Hold	$62.20	19.90% Upside
GKOS Glaukos	2.75	Moderate Buy	$134.67	29.76% Upside
MMSI Merit Medical Systems	2.89	Moderate Buy	$109.11	16.34% Upside

Current Analyst Ratings Breakdown

Latest CNMD, MMSI, GKOS, and BLCO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/9/2025	BLCO Bausch + Lomb	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$13.00 ➝ $15.00
7/8/2025	BLCO Bausch + Lomb	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$15.50 ➝ $16.00
7/8/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$108.00
6/12/2025	CNMD CONMED	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$61.00
6/9/2025	BLCO Bausch + Lomb	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$19.00 ➝ $16.00
5/23/2025	MMSI Merit Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $110.00
5/21/2025	MMSI Merit Medical Systems	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$108.00 ➝ $112.00
5/21/2025	MMSI Merit Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $108.00
5/15/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$100.00 ➝ $108.00
5/6/2025	BLCO Bausch + Lomb	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$18.00 ➝ $12.00
5/6/2025	GKOS Glaukos	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$110.00 ➝ $72.00

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLCO Bausch + Lomb	$4.79B	1.03	$1.87 per share	7.50	$18.57 per share	0.75
CNMD CONMED	$1.31B	1.23	$6.58 per share	7.88	$31.16 per share	1.66
GKOS Glaukos	$404.52M	14.66	N/A	N/A	$13.91 per share	7.46
MMSI Merit Medical Systems	$1.36B	4.09	$5.48 per share	17.12	$23.67 per share	3.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLCO Bausch + Lomb	-$317M	-$1.03	N/A	14.58	1.58	-7.50%	2.62%	1.28%	7/30/2025 (Estimated)
CNMD CONMED	$132.42M	$3.80	13.67	10.23	1.36	9.02%	14.36%	5.86%	7/30/2025 (Estimated)
GKOS Glaukos	-$146.37M	-$2.37	N/A	N/A	N/A	-31.40%	-10.66%	-8.06%	7/30/2025 (Estimated)
MMSI Merit Medical Systems	$120.36M	$2.04	45.97	25.01	3.10	8.81%	15.52%	8.72%	7/30/2025 (Estimated)

Latest CNMD, MMSI, GKOS, and BLCO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	BLCO Bausch + Lomb	$0.07	N/A	N/A	N/A	$1.25 billion	N/A
7/30/2025	Q2 2025	CNMD CONMED	$1.13	N/A	N/A	N/A	$338.42 million	N/A
7/30/2025	Q2 2025	GKOS Glaukos	-$0.26	N/A	N/A	N/A	$115.49 million	N/A
7/30/2025	Q2 2025	MMSI Merit Medical Systems	$0.8480	N/A	N/A	N/A	$372.47 million	N/A
4/30/2025	Q1 2025	BLCO Bausch + Lomb	$0.03	-$0.07	-$0.10	-$0.60	$1.15 billion	$1.15 billion
4/30/2025	Q1 2025	CNMD CONMED	$0.81	$0.95	+$0.14	$0.19	$313.38 million	$321.26 million
4/30/2025	Q1 2025	GKOS Glaukos	-$0.33	-$0.22	+$0.11	-$0.32	$102.78 million	$106.66 million
4/24/2025	Q1 2025	MMSI Merit Medical Systems	$0.75	$0.86	+$0.11	$0.49	$352.57 million	$355.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A
CNMD CONMED	$0.80	1.54%	N/A	21.05%	N/A
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A

Latest CNMD, MMSI, GKOS, and BLCO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	CNMD CONMED	quarterly	$0.20	1.34%	6/13/2025	6/13/2025	7/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLCO Bausch + Lomb	0.74	1.56	0.96
CNMD CONMED	0.91	2.26	1.00
GKOS Glaukos	0.09	6.49	5.62
MMSI Merit Medical Systems	0.51	4.87	3.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLCO Bausch + Lomb	11.07%
CNMD CONMED	N/A
GKOS Glaukos	99.04%
MMSI Merit Medical Systems	99.66%

Insider Ownership

Company	Insider Ownership
BLCO Bausch + Lomb	0.76%
CNMD CONMED	3.10%
GKOS Glaukos	5.80%
MMSI Merit Medical Systems	3.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLCO Bausch + Lomb	13,500	353.80 million	351.03 million	Optionable
CNMD CONMED	3,900	30.94 million	29.98 million	Optionable
GKOS Glaukos	780	57.14 million	53.83 million	Optionable
MMSI Merit Medical Systems	7,400	59.10 million	57.21 million	Optionable

CNMD, MMSI, GKOS, and BLCO Headlines

Recent News About These Companies

Teacher Retirement System of Texas Decreases Stock Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 11 at 4:00 AM | marketbeat.com

Why Merit Medical Systems (MMSI) Stock Is Trading Up Today

July 8 at 6:46 PM | msn.com

Merit Medical is getting a new CEO

July 8 at 1:44 PM | massdevice.com

Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook

July 8 at 1:44 PM | benzinga.com

5MMSI : What 14 Analyst Ratings Have To Say About Merit Medical Systems

July 8 at 1:44 PM | benzinga.com

Needham & Company LLC Reiterates Buy Rating for Merit Medical Systems (NASDAQ:MMSI)

July 8 at 8:20 AM | marketbeat.com

Strategic Leadership Transition and Strong Financial Performance Justify Buy Rating for Merit Medical Systems

July 8 at 7:11 AM | tipranks.com

Hold Rating Maintained for Merit Medical Systems Amid Leadership Change and Cautious Market Outlook

July 8 at 5:40 AM | tipranks.com

Buy Rating for Merit Medical Systems Driven by New CEO Appointment and Strong Revenue Guidance

July 8 at 4:50 AM | tipranks.com

Principal Financial Group Inc. Has $33.82 Million Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 8 at 4:13 AM | marketbeat.com

Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday

July 8 at 2:55 AM | benzinga.com

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

July 7, 2025 | globenewswire.com

Analysts Set Merit Medical Systems, Inc. (NASDAQ:MMSI) PT at $109.11

July 7, 2025 | americanbankingnews.com

Impax Asset Management Group plc Lowers Stock Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 6, 2025 | marketbeat.com

Allspring Global Investments Holdings LLC Increases Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 5, 2025 | marketbeat.com

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of "Moderate Buy" by Brokerages

July 4, 2025 | marketbeat.com

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 3, 2025 | gurufocus.com

Merit Medical Systems Inc (MMSI) Announces Upcoming Financial Results Release and Investor Call ...

July 3, 2025 | gurufocus.com

Merit Medical Systems, Inc. to Release Q2 2025 Financial Results and Host Investor Conference Call on July 30

July 3, 2025 | quiverquant.comQ

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 | MMSI Stock News

July 3, 2025 | gurufocus.com

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 3, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD, MMSI, GKOS, and BLCO Company Descriptions

Bausch + Lomb NYSE:BLCO

$13.88 -0.32 (-2.25%)

Closing price 03:59 PM Eastern

Extended Trading

$13.88 -0.01 (-0.04%)

As of 04:10 PM Eastern

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

CONMED NYSE:CNMD

$51.21 -2.36 (-4.41%)

Closing price 03:58 PM Eastern

Extended Trading

$51.26 +0.05 (+0.11%)

As of 04:20 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Glaukos NYSE:GKOS

$103.68 -2.87 (-2.69%)

Closing price 03:59 PM Eastern

Extended Trading

$103.81 +0.13 (+0.12%)

As of 05:48 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Merit Medical Systems NASDAQ:MMSI

$93.49 -1.68 (-1.77%)

Closing price 04:00 PM Eastern

Extended Trading

$93.46 -0.02 (-0.03%)

As of 04:31 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time